Stay updated on Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer
Sign up to get notified when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.

Latest updates to the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.5%
- Check48 days agoChange DetectedThe web page has been updated to reflect a new version (v2.14.2) of the NLM-NCBI services and products, indicating improvements or changes from the previous version (v2.14.0). Additionally, there is a notice about heavy traffic affecting performance and availability.SummaryDifference0.5%
- Check78 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check100 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
- Check107 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, while removing the previous wording about those conducting the study.SummaryDifference0.9%
- Check121 days agoChange DetectedThe website has been updated from version 2.12.1 to 2.12.2.SummaryDifference0.0%
Stay in the know with updates to Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.